GL Ventures LLC
VC Fund
Beijing, China
GL Ventures LLC is a venture capital affiliate of Hillhouse.
- Total investments:
- 114
- Last investment:
- Lead investor:
- 51%
Last updated:
For AI agents: llms.txt
Industries GL Ventures LLC invests in
Stages GL Ventures LLC invests in
Countries GL Ventures LLC invests in
Round sizes
Round size
- Series A
- $10M–$100M
- Series B
- $14M–$100M
- Series C
- $14M–$230M
Investment Focus
Industry
- Biotechnology 23 (20%)
- Health Care 16 (14%)
- Artificial Intelligence 16 (14%)
- Software 14 (12%)
- Manufacturing 14 (12%)
Stage
- Series A 28 (25%)
- Series B 22 (19%)
- Series C 17 (15%)
- Seed 9 (8%)
- Series D 6 (5%)
Country
- China 71 (62%)
- United States 4 (4%)
- Hong Kong 3 (3%)
- Spain 1 (1%)
- Germany 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Zhibo Quan
|
Quan Zhibo is a developer of robot joints, mainly engaged in the research and development, design, production and sales of robot joints, and provides research and development. | Series A / Jul 03, 2026 | |
XintLabs
|
XintLabs is an innovative sports technology company specializing in AI-driven motion analytics and advanced computer vision . Based in the tech hub of Shenzhen, China, the company develops smart training systems designed specifically for automated biomechanical golf swing analysis . By utilizing proprietary machine learning models, their platformtracks and evaluates athletic body movements without the need for complex wearable sensors. | Angel / Jun 05, 2026 | |
Approaching.AI
|
Approaching.AI is an AI Infra company focusing on the important large model application scenarios such as RAG. | Seed / May 20, 2026 | |
|
SportVision
|
SportVision focused on the research and development of sports algorithms and the application of hardware products, as well as the construction of an AI-intelligent coaching system. | Angel / May 19, 2026 | |
Starna Therapeutics
|
Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields. | $40M / Series B / May 12, 2026 | |
LTZ Therapeutics
|
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | $38M / Venture - Series Unknown / May 06, 2026 | |
|
LTZ Therapeutics
|
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | $38M / Series B / May 06, 2026 | |
Syneron
|
Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $150M / Series B / Mar 31, 2026 | |
|
Reverse Matrix Technology
|
Reverse Matrix Technology offers research and development of world model technology to integrate basic models and reinforcement learning. | Angel / Mar 26, 2026 | |
D-Robotics
|
D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $150M / Series B / Mar 16, 2026 | |
| See all 114 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does GL Ventures LLC invest in?
GL Ventures LLC invests primarily in Biotechnology, Health Care and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 114 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is GL Ventures LLC's check size?
GL Ventures LLC typically joins rounds of $10M–$100M at Series A, $14M–$100M at Series B and $14M–$230M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GL Ventures LLC participates in.
When did GL Ventures LLC last invest?
The most recent investment recorded for GL Ventures LLC closed in Jul 2026. Shizune tracks 114 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
